🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for TME

Long-term Cohort Study of Mesorectal Excision for Rectal Cancer NCT05112016n/a1 site📍 Winterthur Kantonsspital Winterthur KSW · Tests: Total mesorectal excision for rectal cancer Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision NCT07651553NA1 site📍 Guangzhou Sun Yat-sen University · Tests: robotic surgery vs transanal total mesorectal excsion Hyperthermia With Chemoradiotherapy in Rectal Cancer NCT06831981NA2 sites📍 Tübingen📍 Tübingen University Hospital Tuebingen · Tests: Hyperthermia, Radiotherapy, Chemotherapy with 5-fluorouracil, Consolidation chemotherapy with FOLFOX REsults of LOw Anterior Resections With or Without Preventive Stoma in Nonemergency Department NCT07463261NA7 sites📍 Moscow📍 Moscow📍 Moscow ANO Scientific and Practical Club for the Development of Mo… · Tests: Without a preventive stoma, With a preventive stoma Beyond TME Origins NCT02292641NA4 sites📍 Oslo📍 Harrow📍 Oxford Imperial College London · Tests: New Radiological Staging Classification system for patients with advanced and recurrent colorectal cancer undergoing pe… Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore NCT06157996Phase 21 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: lenvatinib and tislelizumab plus CapeOX chemotherapy, tislelizumab plus CapeOX chemotherapy Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma NCT04658303n/a1 site📍 Pittsburgh Yana Najjar · Tests: Pimonidazole CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer NCT05942300Phase 11 site📍 Pittsburgh Lan Coffman · Tests: CPI-0209, carboplatin The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer NCT05984485Phase 36 sites📍 Chongqing📍 Guangzhou📍 Hengyang Sun Yat-sen University · Tests: neoadjuvant chemotherapy plus total mesorectal excision, total mesorectal excision Total Mesorectal Excision(TME) With Lateral Lymph Node Dissection Versus TME After Neoadjuvant Chemo-radiotherapy NCT03587480NA1 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: TME+LLND, TME+nCRT Patient Reported Outcomes Following Cancer of the Rectum NCT04936581n/a2 sites📍 Madrid📍 Madrid University Hospital Gregorio Marañón · Tests: Open Total Mesorectal Excision, Laparoscopic Total Mesorectal Excision, Robotic Total Mesorectal Excision, Transanal To… Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma NCT05516628Phase 26 sites📍 Singapore📍 Singapore📍 Singapore National Cancer Centre, Singapore · Tests: Surgical Resection, Adjuvant Atezolizumab-Bevacizumab Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy